High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer
Bladder cancer is the second most common malignancy of the urinary system, after prostate cancer. The expression of long noncoding RNA MALAT1 can promote cancer cell proliferation, invasion, and metastasis in many tumor types. High MALAT1 expression could serve as an independent prognostic factor fo...
Saved in:
Published in | Clinical genitourinary cancer Vol. 15; no. 5; pp. 570 - 576 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.10.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Bladder cancer is the second most common malignancy of the urinary system, after prostate cancer. The expression of long noncoding RNA MALAT1 can promote cancer cell proliferation, invasion, and metastasis in many tumor types. High MALAT1 expression could serve as an independent prognostic factor for bladder cancer and could be a potential therapeutic target of bladder cancer.
Recent studies have demonstrated that the expression of long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes cancer cell proliferation, invasion, and metastasis in many tumor types, but the association between bladder cancer and MALAT1 remains unknown.
The expression of MALAT1 was tested by in situ hybridization (ISH) in 120 bladder cancer specimens. The association between MALAT1 expression and clinicopathological features and prognosis of the patients with bladder cancer was analyzed. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to verify the relationship between the expression of MALAT1 and progression and metastasis of bladder cancer.
ISH showed that high MALAT1 expression was associated with advanced histological grade, high tumor stage, and positive lymph nodes. Kaplan-Meier survival analysis and Cox regression analysis indicated that high tumor stage, positive lymph nodes, and high MALAT1 expression were independent prognostic indicators for overall survival (OS) of patients with bladder cancer. qRT-PCR showed that the expression of MALAT1 in bladder cancer tissues was 2.85 times higher than those measured in adjacent normal tissues (P < .001). The expression of MALAT1 was 2.673 ± 0.254 in non–muscle-invasive bladder cancer and 2.987 ± 0.381 in muscle-invasive bladder cancer (P = .018). In bladder cancer specimens with positive lymph nodes, MALAT1 expression was 3.167 ± 0.297 versus 2.896 ± 0.329 in bladder cancer specimens with negative lymph nodes (P = .020).
High MALAT1 expression could serve as an independent prognostic factor for OS of patients with bladder cancer and could be considered as a potential therapeutic target of bladder cancer. |
---|---|
AbstractList | Bladder cancer is the second most common malignancy of the urinary system, after prostate cancer. The expression of long noncoding RNA MALAT1 can promote cancer cell proliferation, invasion, and metastasis in many tumor types. High MALAT1 expression could serve as an independent prognostic factor for bladder cancer and could be a potential therapeutic target of bladder cancer.
Recent studies have demonstrated that the expression of long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes cancer cell proliferation, invasion, and metastasis in many tumor types, but the association between bladder cancer and MALAT1 remains unknown.
The expression of MALAT1 was tested by in situ hybridization (ISH) in 120 bladder cancer specimens. The association between MALAT1 expression and clinicopathological features and prognosis of the patients with bladder cancer was analyzed. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to verify the relationship between the expression of MALAT1 and progression and metastasis of bladder cancer.
ISH showed that high MALAT1 expression was associated with advanced histological grade, high tumor stage, and positive lymph nodes. Kaplan-Meier survival analysis and Cox regression analysis indicated that high tumor stage, positive lymph nodes, and high MALAT1 expression were independent prognostic indicators for overall survival (OS) of patients with bladder cancer. qRT-PCR showed that the expression of MALAT1 in bladder cancer tissues was 2.85 times higher than those measured in adjacent normal tissues (P < .001). The expression of MALAT1 was 2.673 ± 0.254 in non–muscle-invasive bladder cancer and 2.987 ± 0.381 in muscle-invasive bladder cancer (P = .018). In bladder cancer specimens with positive lymph nodes, MALAT1 expression was 3.167 ± 0.297 versus 2.896 ± 0.329 in bladder cancer specimens with negative lymph nodes (P = .020).
High MALAT1 expression could serve as an independent prognostic factor for OS of patients with bladder cancer and could be considered as a potential therapeutic target of bladder cancer. BACKGROUNDRecent studies have demonstrated that the expression of long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes cancer cell proliferation, invasion, and metastasis in many tumor types, but the association between bladder cancer and MALAT1 remains unknown.MATERIALSThe expression of MALAT1 was tested by in situ hybridization (ISH) in 120 bladder cancer specimens. The association between MALAT1 expression and clinicopathological features and prognosis of the patients with bladder cancer was analyzed. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to verify the relationship between the expression of MALAT1 and progression and metastasis of bladder cancer.RESULTSISH showed that high MALAT1 expression was associated with advanced histological grade, high tumor stage, and positive lymph nodes. Kaplan-Meier survival analysis and Cox regression analysis indicated that high tumor stage, positive lymph nodes, and high MALAT1 expression were independent prognostic indicators for overall survival (OS) of patients with bladder cancer. qRT-PCR showed that the expression of MALAT1 in bladder cancer tissues was 2.85 times higher than those measured in adjacent normal tissues (P < .001). The expression of MALAT1 was 2.673 ± 0.254 in non-muscle-invasive bladder cancer and 2.987 ± 0.381 in muscle-invasive bladder cancer (P = .018). In bladder cancer specimens with positive lymph nodes, MALAT1 expression was 3.167 ± 0.297 versus 2.896 ± 0.329 in bladder cancer specimens with negative lymph nodes (P = .020).CONCLUSIONHigh MALAT1 expression could serve as an independent prognostic factor for OS of patients with bladder cancer and could be considered as a potential therapeutic target of bladder cancer. Recent studies have demonstrated that the expression of long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes cancer cell proliferation, invasion, and metastasis in many tumor types, but the association between bladder cancer and MALAT1 remains unknown. The expression of MALAT1 was tested by in situ hybridization (ISH) in 120 bladder cancer specimens. The association between MALAT1 expression and clinicopathological features and prognosis of the patients with bladder cancer was analyzed. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to verify the relationship between the expression of MALAT1 and progression and metastasis of bladder cancer. ISH showed that high MALAT1 expression was associated with advanced histological grade, high tumor stage, and positive lymph nodes. Kaplan-Meier survival analysis and Cox regression analysis indicated that high tumor stage, positive lymph nodes, and high MALAT1 expression were independent prognostic indicators for overall survival (OS) of patients with bladder cancer. qRT-PCR showed that the expression of MALAT1 in bladder cancer tissues was 2.85 times higher than those measured in adjacent normal tissues (P < .001). The expression of MALAT1 was 2.673 ± 0.254 in non-muscle-invasive bladder cancer and 2.987 ± 0.381 in muscle-invasive bladder cancer (P = .018). In bladder cancer specimens with positive lymph nodes, MALAT1 expression was 3.167 ± 0.297 versus 2.896 ± 0.329 in bladder cancer specimens with negative lymph nodes (P = .020). High MALAT1 expression could serve as an independent prognostic factor for OS of patients with bladder cancer and could be considered as a potential therapeutic target of bladder cancer. |
Author | Cui, Yu Zu, Xiong-Bing Zhou, Xu Li, Chao Ren, Wen-Biao Li, Qia-Qia Li, Yang Liu, Long-Fei Bai, Xiang-Yang Li, Yang-Le |
Author_xml | – sequence: 1 givenname: Chao surname: Li fullname: Li, Chao organization: Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan Province, PR China – sequence: 2 givenname: Yu surname: Cui fullname: Cui, Yu organization: Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan Province, PR China – sequence: 3 givenname: Long-Fei surname: Liu fullname: Liu, Long-Fei organization: Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan Province, PR China – sequence: 4 givenname: Wen-Biao surname: Ren fullname: Ren, Wen-Biao organization: Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan Province, PR China – sequence: 5 givenname: Qia-Qia surname: Li fullname: Li, Qia-Qia organization: Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan Province, PR China – sequence: 6 givenname: Xu surname: Zhou fullname: Zhou, Xu organization: Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan Province, PR China – sequence: 7 givenname: Yang-Le surname: Li fullname: Li, Yang-Le organization: Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan Province, PR China – sequence: 8 givenname: Yang surname: Li fullname: Li, Yang organization: Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan Province, PR China – sequence: 9 givenname: Xiang-Yang surname: Bai fullname: Bai, Xiang-Yang organization: Dliner Bioelectrical LLC, Jiangyin, Wuxi, Jiangsu Province, PR China – sequence: 10 givenname: Xiong-Bing surname: Zu fullname: Zu, Xiong-Bing email: whzuxb@163.com organization: Department of Urology, Xiangya Hospital, Central South University, Changsha, Hunan Province, PR China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28648755$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1uGyEUhVGVqvnrC2RRscxmpvwMA5a6cay0ieSkUZSuEQN3HKwxuDCO0mfoS_RZ-mRl6qTLIiQu3O8ciXuO0UGIARA6o6SmhLYf17UdVrZmhMqaiJoQ-gYd0RlXFWkVOyi1EKqSreSH6DjnNSGNoJK8Q4dMtY2SQhyhn1d-9Ygvn7cJcvYx4NjjZQwrfBuDjc6X6v52jm_my_kDxdfBeWtGyNjguxgTvktxFWL25SG46baJU3cx-FDA4W__1XkibmA0uewi8OH3r4vBOAcJL0ywkE7R294MGd6_nCfo2-fLh8VVtfz65XoxX1aWi3asBHNcqU4Ac9IR2zZS8rZltle2t66THeW0K4sLaoA2jWJN5wAMtVxCJzk_Qed7322K33eQR73x2cIwmABxlzWdUa44k2RWULZHbYo5J-j1NvmNST80JXoKQa_1FIKeQtBE6BJCEX148d91G3D_JK9TL8CnPQDll08eks7WQxmB8wnsqF30__P_A_ljm98 |
CitedBy_id | crossref_primary_10_3389_fphys_2018_00652 crossref_primary_10_1042_BSR20210908 crossref_primary_10_1007_s12551_017_0379_y crossref_primary_10_3892_mmr_2018_9094 crossref_primary_10_1016_j_humgen_2023_201164 crossref_primary_10_1111_jcmm_13578 crossref_primary_10_1002_mc_22806 crossref_primary_10_1186_s12911_020_1115_2 crossref_primary_10_1080_21655979_2021_1955511 crossref_primary_10_29254_2077_4214_2019_2_1_150_109_112 crossref_primary_10_3389_fgene_2024_1356205 crossref_primary_10_3892_ol_2019_11184 crossref_primary_10_1007_s12010_022_04136_8 crossref_primary_10_1016_j_canlet_2020_04_023 crossref_primary_10_1002_jbt_22452 crossref_primary_10_1042_BSR20200215 crossref_primary_10_3390_ijms24129854 crossref_primary_10_1016_j_genrep_2020_101010 crossref_primary_10_12677_ACM_2024_143839 crossref_primary_10_3892_etm_2019_7960 crossref_primary_10_3389_fonc_2021_648968 crossref_primary_10_1039_C8RA04876B crossref_primary_10_2174_1875318302111010115 crossref_primary_10_3727_096504018X15190844870055 crossref_primary_10_1002_cam4_1677 crossref_primary_10_18632_oncotarget_23483 crossref_primary_10_1016_j_prp_2019_04_021 crossref_primary_10_1186_s13578_020_0373_0 crossref_primary_10_3892_ijmm_2018_3959 crossref_primary_10_1038_s41419_018_0925_y crossref_primary_10_2147_CMAR_S276022 crossref_primary_10_3389_fcell_2021_672679 crossref_primary_10_1016_j_prp_2024_155226 crossref_primary_10_3390_molecules28052412 crossref_primary_10_1155_2022_3459855 crossref_primary_10_1002_jcb_29025 crossref_primary_10_1016_j_cca_2020_01_008 crossref_primary_10_1016_j_heliyon_2019_e02785 crossref_primary_10_2147_OTT_S250796 crossref_primary_10_3389_fonc_2021_710538 crossref_primary_10_1016_j_yexmp_2019_104330 crossref_primary_10_1002_ctm2_310 crossref_primary_10_3389_fgene_2022_1051762 crossref_primary_10_3390_cancers12113220 crossref_primary_10_1016_j_biopha_2018_04_087 crossref_primary_10_1186_s12935_018_0606_z crossref_primary_10_3390_ncrna4030020 crossref_primary_10_3390_ijms23147656 crossref_primary_10_1002_ijc_34282 crossref_primary_10_1186_s13045_018_0606_4 |
Cites_doi | 10.1039/C6NR09668A 10.3892/mmr.2016.5534 10.1097/MOU.0000000000000090 10.1007/978-3-642-16502-3_1 10.1007/s13277-014-2850-8 10.18632/oncotarget.8257 10.1007/s12032-011-0004-z 10.1038/srep15972 10.18632/oncotarget.7367 10.1002/bies.201100025 10.1038/sj.onc.1206928 10.1016/j.cell.2011.03.014 10.1097/JTO.0b013e3182307eac 10.1002/jso.23214 10.1002/cncr.28509 10.1016/j.bbrc.2014.02.006 10.18632/oncotarget.6059 10.4161/rna.20481 10.3322/caac.21332 10.1007/s00120-014-3655-5 10.1039/c2mb25070e 10.1186/1476-4598-12-101 10.1016/j.cellsig.2014.01.022 10.1074/jbc.M114.596866 10.1016/j.febslet.2013.10.023 10.1158/1078-0432.CCR-13-1455 10.1371/journal.pone.0117809 10.1007/s13277-015-3870-8 10.18632/oncotarget.12880 |
ContentType | Journal Article |
Copyright | 2017 Elsevier Inc. Copyright © 2017 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2017 Elsevier Inc. – notice: Copyright © 2017 Elsevier Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.clgc.2017.05.001 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1938-0682 |
EndPage | 576 |
ExternalDocumentID | 10_1016_j_clgc_2017_05_001 28648755 S1558767317301258 |
Genre | Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1P~ 1~. 29B 4.4 457 4G. 53G 5GY 6J9 6PF 7-5 8P~ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQQT AAWTL AAXUO ABBQC ABDBF ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFS ACRLP ADBBV ADEZE ADMUD AEBSH AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV C45 CAG COF DU5 EBS EFJIC EFLBG EJD ESX F5P FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HZ~ KOM LCYCR M41 MET MO0 O-L O9- OAUVE OC~ OO- OVD P-8 P-9 PC. Q38 ROL SDF SEL SPCBC SSH SSZ T5K TEORI XH2 Z5R ~G- AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF EMOBN NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c356t-52d388b5e2d7d0c64773662cf8cfcdb7b131bbbb351ae144824bdeea1c37eb733 |
IEDL.DBID | AIKHN |
ISSN | 1558-7673 |
IngestDate | Sat Aug 17 01:04:49 EDT 2024 Thu Sep 26 17:06:23 EDT 2024 Wed Oct 16 00:59:12 EDT 2024 Fri Feb 23 02:23:34 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Lymph node metastasis Tumor biology Survival analysis Biomarker Diagnosis |
Language | English |
License | Copyright © 2017 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c356t-52d388b5e2d7d0c64773662cf8cfcdb7b131bbbb351ae144824bdeea1c37eb733 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 28648755 |
PQID | 1913832709 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1913832709 crossref_primary_10_1016_j_clgc_2017_05_001 pubmed_primary_28648755 elsevier_sciencedirect_doi_10_1016_j_clgc_2017_05_001 |
PublicationCentury | 2000 |
PublicationDate | October 2017 2017-Oct 2017-10-00 20171001 |
PublicationDateYYYYMMDD | 2017-10-01 |
PublicationDate_xml | – month: 10 year: 2017 text: October 2017 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Clinical genitourinary cancer |
PublicationTitleAlternate | Clin Genitourin Cancer |
PublicationYear | 2017 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Noon, Catto (bib16) 2014; 24 Gutschner, Diederichs (bib5) 2012; 9 Hu, Wang, Guo (bib26) 2016; 7 Ji, Diederichs, Wang (bib7) 2003; 22 Zhao, Chen, Liu, Wu (bib11) 2014; 445 Siegel, Miller, Jemal (bib1) 2016; 66 Ying, Chen, Wang, Zhou, Huang, Qiu (bib13) 2012; 8 Zhang, Su, Lu, Wang (bib3) 2013; 12 Pandey, Kanduri (bib6) 2011; 51 Lai, Yang, Zhou (bib9) 2012; 29 Zhou, Liu, Cai (bib25) 2015; 5 Pang, Yang, Fu, Liu (bib12) 2015; 36 Wang, Wang, Zhang (bib10) 2014; 26 Wang, Zhu, Li (bib27) 2016; 7 Han, Liu, Gui, Cai (bib15) 2013; 107 Han, Liu, Zhang (bib17) 2013; 587 Soto, Sonnenschein (bib29) 2011; 33 Duan, Du, Jiang (bib18) 2016; 7 Schmidt, Spieker, Koschmieder (bib8) 2011; 6 Liu, Xing, Chen (bib22) 2015; 6 Li, Ren, Liu, Pan, Xu, Yang (bib23) 2017; 9 Wang, Li, Wang (bib24) 2015; 290 Lei, Li, Tong (bib21) 2015; 10 Kohls, Schmidt, Holdenrieder, Muller, Ellinger (bib28) 2015; 54 Long, Wu, Yang (bib20) 2016; 14 Nagano, Fraser (bib4) 2011; 145 Wu, Lu, Xu, Shi, Zhang, Xia (bib19) 2016; 37 Edwards, Noone, Mariotto (bib2) 2014; 120 Fan, Shen, Tan (bib14) 2014; 20 Pandey (10.1016/j.clgc.2017.05.001_bib6) 2011; 51 Wu (10.1016/j.clgc.2017.05.001_bib19) 2016; 37 Lei (10.1016/j.clgc.2017.05.001_bib21) 2015; 10 Long (10.1016/j.clgc.2017.05.001_bib20) 2016; 14 Han (10.1016/j.clgc.2017.05.001_bib15) 2013; 107 Wang (10.1016/j.clgc.2017.05.001_bib24) 2015; 290 Pang (10.1016/j.clgc.2017.05.001_bib12) 2015; 36 Han (10.1016/j.clgc.2017.05.001_bib17) 2013; 587 Liu (10.1016/j.clgc.2017.05.001_bib22) 2015; 6 Soto (10.1016/j.clgc.2017.05.001_bib29) 2011; 33 Wang (10.1016/j.clgc.2017.05.001_bib10) 2014; 26 Zhou (10.1016/j.clgc.2017.05.001_bib25) 2015; 5 Noon (10.1016/j.clgc.2017.05.001_bib16) 2014; 24 Lai (10.1016/j.clgc.2017.05.001_bib9) 2012; 29 Ying (10.1016/j.clgc.2017.05.001_bib13) 2012; 8 Li (10.1016/j.clgc.2017.05.001_bib23) 2017; 9 Gutschner (10.1016/j.clgc.2017.05.001_bib5) 2012; 9 Edwards (10.1016/j.clgc.2017.05.001_bib2) 2014; 120 Nagano (10.1016/j.clgc.2017.05.001_bib4) 2011; 145 Hu (10.1016/j.clgc.2017.05.001_bib26) 2016; 7 Schmidt (10.1016/j.clgc.2017.05.001_bib8) 2011; 6 Duan (10.1016/j.clgc.2017.05.001_bib18) 2016; 7 Fan (10.1016/j.clgc.2017.05.001_bib14) 2014; 20 Kohls (10.1016/j.clgc.2017.05.001_bib28) 2015; 54 Ji (10.1016/j.clgc.2017.05.001_bib7) 2003; 22 Zhao (10.1016/j.clgc.2017.05.001_bib11) 2014; 445 Siegel (10.1016/j.clgc.2017.05.001_bib1) 2016; 66 Zhang (10.1016/j.clgc.2017.05.001_bib3) 2013; 12 Wang (10.1016/j.clgc.2017.05.001_bib27) 2016; 7 |
References_xml | – volume: 8 start-page: 2289 year: 2012 end-page: 2294 ident: bib13 article-title: Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition publication-title: Mol Biosyst contributor: fullname: Qiu – volume: 587 start-page: 3875 year: 2013 end-page: 3882 ident: bib17 article-title: Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long noncoding RNA MALAT1 publication-title: FEBS Lett contributor: fullname: Zhang – volume: 7 start-page: 25668 year: 2016 end-page: 25682 ident: bib27 article-title: Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting beta-catenin via Ezh2 publication-title: Oncotarget contributor: fullname: Li – volume: 20 start-page: 1531 year: 2014 end-page: 1541 ident: bib14 article-title: TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12 publication-title: Clin Cancer Res contributor: fullname: Tan – volume: 24 start-page: 506 year: 2014 end-page: 511 ident: bib16 article-title: Noncoding RNA in bladder cancer: a specific focus upon high-risk nonmuscle invasive disease publication-title: Curr Opin Urol contributor: fullname: Catto – volume: 33 start-page: 332 year: 2011 end-page: 340 ident: bib29 article-title: The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory publication-title: Bioessays contributor: fullname: Sonnenschein – volume: 290 start-page: 3925 year: 2015 end-page: 3935 ident: bib24 article-title: Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells publication-title: J Biol Chem contributor: fullname: Wang – volume: 7 start-page: 78850 year: 2016 end-page: 78858 ident: bib18 article-title: Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer publication-title: Oncotarget contributor: fullname: Jiang – volume: 37 start-page: 897 year: 2016 end-page: 903 ident: bib19 article-title: Prognostic value of long non-coding RNA MALAT1 in cancer patients publication-title: Tumour Biol contributor: fullname: Xia – volume: 5 start-page: 15972 year: 2015 ident: bib25 article-title: Long non coding RNA MALAT1 promotes tumor growth and metastasis by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma publication-title: Sci Rep contributor: fullname: Cai – volume: 107 start-page: 201 year: 2013 end-page: 205 ident: bib15 article-title: Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder publication-title: J Surg Oncol contributor: fullname: Cai – volume: 120 start-page: 1290 year: 2014 end-page: 1314 ident: bib2 article-title: Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer publication-title: Cancer contributor: fullname: Mariotto – volume: 6 start-page: 1984 year: 2011 end-page: 1992 ident: bib8 article-title: The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth publication-title: J Thorac Oncol contributor: fullname: Koschmieder – volume: 36 start-page: 2403 year: 2015 end-page: 2407 ident: bib12 article-title: Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer publication-title: Tumour Biol contributor: fullname: Liu – volume: 26 start-page: 1048 year: 2014 end-page: 1059 ident: bib10 article-title: Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer publication-title: Cell Signal contributor: fullname: Zhang – volume: 145 start-page: 178 year: 2011 end-page: 181 ident: bib4 article-title: No-nonsense functions for long noncoding RNAs publication-title: Cell contributor: fullname: Fraser – volume: 9 start-page: 2521 year: 2017 end-page: 2530 ident: bib23 article-title: MicroRNA-mediated silence of onco-lncRNA MALAT1 in different ESCC cells via ligand-functionalized hydroxyl-rich nanovectors publication-title: Nanoscale contributor: fullname: Yang – volume: 7 start-page: 11733 year: 2016 end-page: 11743 ident: bib26 article-title: Long non-coding RNA MALAT1 increases AKAP-9 expression by promoting SRPK1-catalyzed SRSF1 phosphorylation in colorectal cancer cells publication-title: Oncotarget contributor: fullname: Guo – volume: 14 start-page: 2651 year: 2016 end-page: 2656 ident: bib20 article-title: MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS publication-title: Mol Med Rep contributor: fullname: Yang – volume: 54 start-page: 819 year: 2015 end-page: 825 ident: bib28 article-title: Detection of cell-free lncRNA in serum of cancer patients publication-title: Urologe A contributor: fullname: Ellinger – volume: 29 start-page: 1810 year: 2012 end-page: 1816 ident: bib9 article-title: Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation publication-title: Med Oncol contributor: fullname: Zhou – volume: 9 start-page: 703 year: 2012 end-page: 719 ident: bib5 article-title: The hallmarks of cancer: a long non-coding RNA point of view publication-title: RNA Biol contributor: fullname: Diederichs – volume: 445 start-page: 388 year: 2014 end-page: 393 ident: bib11 article-title: 17beta-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level publication-title: Biochem Biophys Res Commun contributor: fullname: Wu – volume: 51 start-page: 1 year: 2011 end-page: 27 ident: bib6 article-title: Transcriptional and posttranscriptional programming by long noncoding RNAs publication-title: Prog Mol Subcell Biol contributor: fullname: Kanduri – volume: 66 start-page: 7 year: 2016 end-page: 30 ident: bib1 article-title: Cancer statistics, 2016 publication-title: CA Cancer J Clin contributor: fullname: Jemal – volume: 10 start-page: e0117809 year: 2015 ident: bib21 article-title: miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells publication-title: PLoS One contributor: fullname: Tong – volume: 6 start-page: 37458 year: 2015 end-page: 37470 ident: bib22 article-title: MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers publication-title: Oncotarget contributor: fullname: Chen – volume: 12 start-page: 101 year: 2013 ident: bib3 article-title: The complexity of bladder cancer: long noncoding RNAs are on the stage publication-title: Mol Cancer contributor: fullname: Wang – volume: 22 start-page: 8031 year: 2003 end-page: 8041 ident: bib7 article-title: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer publication-title: Oncogene contributor: fullname: Wang – volume: 9 start-page: 2521 year: 2017 ident: 10.1016/j.clgc.2017.05.001_bib23 article-title: MicroRNA-mediated silence of onco-lncRNA MALAT1 in different ESCC cells via ligand-functionalized hydroxyl-rich nanovectors publication-title: Nanoscale doi: 10.1039/C6NR09668A contributor: fullname: Li – volume: 14 start-page: 2651 year: 2016 ident: 10.1016/j.clgc.2017.05.001_bib20 article-title: MicroRNA-101 inhibits the proliferation and invasion of bladder cancer cells via targeting c-FOS publication-title: Mol Med Rep doi: 10.3892/mmr.2016.5534 contributor: fullname: Long – volume: 24 start-page: 506 year: 2014 ident: 10.1016/j.clgc.2017.05.001_bib16 article-title: Noncoding RNA in bladder cancer: a specific focus upon high-risk nonmuscle invasive disease publication-title: Curr Opin Urol doi: 10.1097/MOU.0000000000000090 contributor: fullname: Noon – volume: 51 start-page: 1 year: 2011 ident: 10.1016/j.clgc.2017.05.001_bib6 article-title: Transcriptional and posttranscriptional programming by long noncoding RNAs publication-title: Prog Mol Subcell Biol doi: 10.1007/978-3-642-16502-3_1 contributor: fullname: Pandey – volume: 36 start-page: 2403 year: 2015 ident: 10.1016/j.clgc.2017.05.001_bib12 article-title: Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer publication-title: Tumour Biol doi: 10.1007/s13277-014-2850-8 contributor: fullname: Pang – volume: 7 start-page: 25668 year: 2016 ident: 10.1016/j.clgc.2017.05.001_bib27 article-title: Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting beta-catenin via Ezh2 publication-title: Oncotarget doi: 10.18632/oncotarget.8257 contributor: fullname: Wang – volume: 29 start-page: 1810 year: 2012 ident: 10.1016/j.clgc.2017.05.001_bib9 article-title: Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation publication-title: Med Oncol doi: 10.1007/s12032-011-0004-z contributor: fullname: Lai – volume: 5 start-page: 15972 year: 2015 ident: 10.1016/j.clgc.2017.05.001_bib25 article-title: Long non coding RNA MALAT1 promotes tumor growth and metastasis by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma publication-title: Sci Rep doi: 10.1038/srep15972 contributor: fullname: Zhou – volume: 7 start-page: 11733 year: 2016 ident: 10.1016/j.clgc.2017.05.001_bib26 article-title: Long non-coding RNA MALAT1 increases AKAP-9 expression by promoting SRPK1-catalyzed SRSF1 phosphorylation in colorectal cancer cells publication-title: Oncotarget doi: 10.18632/oncotarget.7367 contributor: fullname: Hu – volume: 33 start-page: 332 year: 2011 ident: 10.1016/j.clgc.2017.05.001_bib29 article-title: The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory publication-title: Bioessays doi: 10.1002/bies.201100025 contributor: fullname: Soto – volume: 22 start-page: 8031 year: 2003 ident: 10.1016/j.clgc.2017.05.001_bib7 article-title: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer publication-title: Oncogene doi: 10.1038/sj.onc.1206928 contributor: fullname: Ji – volume: 145 start-page: 178 year: 2011 ident: 10.1016/j.clgc.2017.05.001_bib4 article-title: No-nonsense functions for long noncoding RNAs publication-title: Cell doi: 10.1016/j.cell.2011.03.014 contributor: fullname: Nagano – volume: 6 start-page: 1984 year: 2011 ident: 10.1016/j.clgc.2017.05.001_bib8 article-title: The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth publication-title: J Thorac Oncol doi: 10.1097/JTO.0b013e3182307eac contributor: fullname: Schmidt – volume: 107 start-page: 201 year: 2013 ident: 10.1016/j.clgc.2017.05.001_bib15 article-title: Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder publication-title: J Surg Oncol doi: 10.1002/jso.23214 contributor: fullname: Han – volume: 120 start-page: 1290 year: 2014 ident: 10.1016/j.clgc.2017.05.001_bib2 article-title: Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer publication-title: Cancer doi: 10.1002/cncr.28509 contributor: fullname: Edwards – volume: 445 start-page: 388 year: 2014 ident: 10.1016/j.clgc.2017.05.001_bib11 article-title: 17beta-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2014.02.006 contributor: fullname: Zhao – volume: 6 start-page: 37458 year: 2015 ident: 10.1016/j.clgc.2017.05.001_bib22 article-title: MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers publication-title: Oncotarget doi: 10.18632/oncotarget.6059 contributor: fullname: Liu – volume: 9 start-page: 703 year: 2012 ident: 10.1016/j.clgc.2017.05.001_bib5 article-title: The hallmarks of cancer: a long non-coding RNA point of view publication-title: RNA Biol doi: 10.4161/rna.20481 contributor: fullname: Gutschner – volume: 66 start-page: 7 year: 2016 ident: 10.1016/j.clgc.2017.05.001_bib1 article-title: Cancer statistics, 2016 publication-title: CA Cancer J Clin doi: 10.3322/caac.21332 contributor: fullname: Siegel – volume: 54 start-page: 819 year: 2015 ident: 10.1016/j.clgc.2017.05.001_bib28 article-title: Detection of cell-free lncRNA in serum of cancer patients publication-title: Urologe A doi: 10.1007/s00120-014-3655-5 contributor: fullname: Kohls – volume: 8 start-page: 2289 year: 2012 ident: 10.1016/j.clgc.2017.05.001_bib13 article-title: Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition publication-title: Mol Biosyst doi: 10.1039/c2mb25070e contributor: fullname: Ying – volume: 12 start-page: 101 year: 2013 ident: 10.1016/j.clgc.2017.05.001_bib3 article-title: The complexity of bladder cancer: long noncoding RNAs are on the stage publication-title: Mol Cancer doi: 10.1186/1476-4598-12-101 contributor: fullname: Zhang – volume: 26 start-page: 1048 year: 2014 ident: 10.1016/j.clgc.2017.05.001_bib10 article-title: Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer publication-title: Cell Signal doi: 10.1016/j.cellsig.2014.01.022 contributor: fullname: Wang – volume: 290 start-page: 3925 year: 2015 ident: 10.1016/j.clgc.2017.05.001_bib24 article-title: Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells publication-title: J Biol Chem doi: 10.1074/jbc.M114.596866 contributor: fullname: Wang – volume: 587 start-page: 3875 year: 2013 ident: 10.1016/j.clgc.2017.05.001_bib17 article-title: Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long noncoding RNA MALAT1 publication-title: FEBS Lett doi: 10.1016/j.febslet.2013.10.023 contributor: fullname: Han – volume: 20 start-page: 1531 year: 2014 ident: 10.1016/j.clgc.2017.05.001_bib14 article-title: TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-13-1455 contributor: fullname: Fan – volume: 10 start-page: e0117809 year: 2015 ident: 10.1016/j.clgc.2017.05.001_bib21 article-title: miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells publication-title: PLoS One doi: 10.1371/journal.pone.0117809 contributor: fullname: Lei – volume: 37 start-page: 897 year: 2016 ident: 10.1016/j.clgc.2017.05.001_bib19 article-title: Prognostic value of long non-coding RNA MALAT1 in cancer patients publication-title: Tumour Biol doi: 10.1007/s13277-015-3870-8 contributor: fullname: Wu – volume: 7 start-page: 78850 year: 2016 ident: 10.1016/j.clgc.2017.05.001_bib18 article-title: Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer publication-title: Oncotarget doi: 10.18632/oncotarget.12880 contributor: fullname: Duan |
SSID | ssj0045170 |
Score | 2.4242861 |
Snippet | Bladder cancer is the second most common malignancy of the urinary system, after prostate cancer. The expression of long noncoding RNA MALAT1 can promote... Recent studies have demonstrated that the expression of long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes cancer cell... BACKGROUNDRecent studies have demonstrated that the expression of long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) promotes... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 570 |
SubjectTerms | Adult Biomarker Diagnosis Disease Progression Female Gene Expression Regulation, Neoplastic Humans In Situ Hybridization, Fluorescence Lymph node metastasis Male Middle Aged Neoplasm Invasiveness Neoplasm Metastasis Neoplasm Staging Prognosis RNA, Long Noncoding - genetics Survival Analysis Tumor biology Up-Regulation Urinary Bladder Neoplasms - genetics Urinary Bladder Neoplasms - pathology |
Title | High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer |
URI | https://dx.doi.org/10.1016/j.clgc.2017.05.001 https://www.ncbi.nlm.nih.gov/pubmed/28648755 https://search.proquest.com/docview/1913832709 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbJBkovpe9uH0GF3oq7tiXZ2qO7JGy62SWkCc1NWA-HLYsUnA3klD_QP9Hf0l_WGVsuFNoe6ouxpJGFZjQP9I1EyDsw8ZpLlya1zacJN4VJapemiXWZaJxNjbQdQHZVzM_5pwtxsUNmQy4Mwiqj7u91eqetY8kkzubkar2efAZLCEu5BAMIQpoLuUv2wBxxPiJ71dFivhoUMhdZd2cctk-QIObO9DAvs7nEkwyz_gDPeDfMH-zT3_zPzg4dPiQPogNJq36Mj8iO84_JvWXcIn9CviFygx7cRoCrp6Ghx8Ff0lXwJqCloqerii6r4-oso0fedklw17SmJyG09KQNCL1bQ4G3-AWshNp4fOimqx96xhZLt63BwUSCtf_x_eMGNVlLZyhM7VNyfnhwNpsn8caFxDBRbCEqtUxKLVxuS-ATJqmyoshNI01jrC51xjINDxNZ7WCqZc61da7ODCudLhl7RkY-ePeCUCCQBZ-WzhnOa9tI6FoIq5u0sOCVsjF5P8yzuuoP1lAD4uyrQq4o5IpKBcLuxkQMrFC_iYcCzf9PurcD3xSsG9wMqb0LN9cK4lQIzvMynY7J856hv8aRw8ghjhMv__Ovr8h9_Ooxf6_JaNveuDfgu2z1Ptn9cJftRwnF9-L0y-InWazwrw |
link.rule.ids | 315,786,790,4521,24144,27955,27956,45618,45712 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbpBtpeQt_dpg8VeitmLUuytUd3Sdhtdk1oN5CbsB4OWxYpOBvIf8if6G_JL8vIlguFtof6ZksjC81oHuibEUKfwMQrJmya1CabJkznOqltmibGEt5Yk2phOoBslc_P2Ndzfr6HZkMuTIBVRt3f6_ROW8cvk7iak8vNZvIdLCFs5QIMIAhpxsUDtM94QbIR2i8XJ_NqUMiMk-7OuNA_CQQxd6aHeentRahkSPoCnvFumD_Yp7_5n50dOn6CDqIDict-jk_RnnXP0MNVPCJ_jm4DcgMf3USAq8O-wUvvLnDlnfbBUuFvVYlX5bJcE7xwpkuCu8I1PvW-xaetD9C7DXxwJrwBK6E1lg_ddu3DyKHHyu5qcDADwcbd_fyyDZqsxbMgTO0LdHZ8tJ7Nk3jjQqIpz3cQlRoqhOI2MwXwKSSp0jzPdCN0o40qFKFEwUM5qS2EYiJjylhbE00LqwpKX6KR886-RhgIRM6mhbWasdo0Aobm3KgmzQ14pXSMPg_rLC_7whpyQJz9kIErMnBFpjzA7saID6yQv4mHBM3_T7qPA98k7JtwGFI766-vJMSpEJxnRTodo1c9Q3_NI4OZQxzH3_znXz-gR_P1aimXi-rkED0OLT3-7y0a7dpr-w78mJ16H-X0Hpnj8Pw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+Expression+of+Long+Noncoding+RNA+MALAT1+Indicates+a+Poor+Prognosis+and+Promotes+Clinical+Progression+and+Metastasis+in%C2%A0Bladder+Cancer&rft.jtitle=Clinical+genitourinary+cancer&rft.au=Li%2C+Chao&rft.au=Cui%2C+Yu&rft.au=Liu%2C+Long-Fei&rft.au=Ren%2C+Wen-Biao&rft.date=2017-10-01&rft.issn=1558-7673&rft.volume=15&rft.issue=5&rft.spage=570&rft.epage=576&rft_id=info:doi/10.1016%2Fj.clgc.2017.05.001&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_clgc_2017_05_001 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1558-7673&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1558-7673&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1558-7673&client=summon |